top of page
Contact Us
Contact Us

More case studies

Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted.

Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial

From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days.

CSI's 72-hour Abraxane Rescue Mission

Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant.

CSI’s Expert Delivery of a Global Respiratory Study

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Rescuing a Biotech’s Oncology Trial with Lenvima

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

Request

A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a Phase II ophthalmology clinical trial. The study required precise planning and timely execution to ensure uninterrupted supply across multiple global sites. The client prioritised batch consistency and Certificates of Analysis (CoA) for all supplies.

Challenge

The biotech client faced several hurdles in sourcing Lucentis for their study:


Lucentis, being a high-demand ophthalmology drug, had limited availability in the required markets. Additionally, the client required detailed Certificates of Analysis (CoA) for each batch to ensure quality and to ensure that the sourced drug met regulatory requirements across different countries.


To make matters more complex, the client required a single batch to maintain uniformity across batches to avoid variability in trial results. The study had stringent timelines, leaving no room for delays in procurement or delivery.

Solution

CSI leveraged its expertise and global network to address the client’s needs. Utilizing CSI’s established relationships with manufacturers and distributors, the team secured sufficient quantities of Lucentis, considering multiple purchases throughout the study according to the shelf life of the product.


The sourcing strategy also focused on regions with regulatory alignment to the study’s requirements and through careful planning, CSI sourced Lucentis from the same production lots whenever possible, ensuring batch-to-batch consistency.

Case Study

Comparator Sourcing for a Phase II Ophthalmology Study

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Request

The clinical trial proceeded without delays and the client acknowledged CSI’s contribution as instrumental in meeting their ambitious timelines

Challenge

Limited availability of high-demand drug Lucentis, need for batch consistency,
regulatory compliance, and strict timelines.

Solution

CSI leveraged its global network to secure Lucentis, prioritized regulatory-aligned sourcing, ensured batch consistency, and optimized logistics for timely delivery.

Contact us 

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

bottom of page